As of November 10, 2026, Surrozen, Inc./DE is a publicly traded company (Nasdaq: SRZN). The largest holder reporting an active stake on Schedule 13D is The Column Group III GP, LP, at 21.4%. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13D/A, November 6, 2026).
Is this your company?
About to sign with, pay or invest in Surrozen, Inc./DE? See the free Snapshot first.
Free to see. No signup.
Is Surrozen, Inc./DE a real, registered company?
- Surrozen, Inc. files with the SEC under CIK 1824893 (its SEC filings).
- Its shares are listed under the ticker SRZN on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in South San Francisco, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Surrozen, Inc./DE in our court records and SEC 8-K records (as of 2026-11-10).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names The Column Group III GP, LP (filed 2026-11-06).
Who are Surrozen, Inc./DE's owners and officers?
Surrozen, Inc./DE: incorporated in Delaware; business address in South San Francisco, California; industry Biological Products, (No Diagnostic Substances) (Schedule 13D/A, 2026-11-06).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2025-04-08)
- : Executive Officer (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
- : Executive Officer (Form D, 2025-04-08)
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-11-06 | The Column Group Iii Gp, LP | 21.4% |
| Schedule 13D/A, 2026-10-22 | The Column Group Iii Gp, LP | 21.5% |
| Schedule 13G/A, 2026-10-07 | Boxer Capital Management, LLC | 11.6% |
| Schedule 13G, 2026-10-01 | Commodore Capital LP | 7.5% |
| Schedule 13G, 2026-08-14 | Stempoint Capital LP | 5% |
| Schedule 13G/A, 2026-08-14 | Braidwell LP | 3.9% |
| Schedule 13G/A, 2026-08-14 | Boxer Capital Management, LLC | 8.9% |
| Schedule 13G/A, 2026-08-11 | 5am Partners Vii, LLC | 7.8% |
| Schedule 13G/A, 2026-07-24 | Chen Yu | 9.9% |
| Schedule 13D/A, 2026-05-18 | The Column Group Iii Gp, LP | 29.3% |
| Schedule 13G/A, 2026-05-15 | Nantahala Capital Management, LLC | 2.14% |
| Schedule 13G/A, 2026-05-15 | Venrock Healthcare Capital Partners Iii, L.P. | 9.9% |
Questions about who owns Surrozen, Inc./DE
Who owns Surrozen, Inc./DE?
On this page, 7 holders' latest ownership filings report 5% or more of Surrozen, Inc./DE: The Column Group Iii Gp, LP (21.4%, Schedule 13D/A, filed 2026-11-06), Boxer Capital Management, LLC (11.6%, Schedule 13G/A, filed 2026-10-07), Chen Yu (9.9%, Schedule 13G/A, filed 2026-07-24), Venrock Healthcare Capital Partners Iii, L.P. (9.9%, Schedule 13G/A, filed 2026-05-15) and 5am Partners Vii, LLC (7.8%, Schedule 13G/A, filed 2026-08-11); 2 more are listed above.
Who are the largest shareholders of Surrozen, Inc./DE?
By the share each holder's latest filing reports, the largest holders of Surrozen, Inc./DE on this page are The Column Group Iii Gp, LP (21.4%), Boxer Capital Management, LLC (11.6%) and Chen Yu (9.9%).
When did The Column Group Iii Gp, LP buy into Surrozen, Inc./DE?
The filings give report dates, not purchase dates. The earliest filing from The Column Group Iii Gp, LP on this page is the Schedule 13D/A, filed 2026-05-18, reporting 29.3%; its latest, Schedule 13D/A filed 2026-11-06, reports 21.4%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Surrozen, Inc./DE?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Surrozen, Inc./DE: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Surrozen, Inc./DE covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Surrozen, Inc./DE shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Column Group III GP, LP, a 10% owner: 3,813,501 shares (20.0% of shares outstanding), held indirectly through By The Column Group III, LP and 2 others, on a joint filing (Form 4, 2026-10-22).
- Column Group Iii-a, LP, a 10% owner: 3,813,501 shares (20.0% of shares outstanding), held indirectly through By The Column Group III, LP and 2 others, on a joint filing (Form 4, 2026-10-22).
- , a director and 10% owner: 3,813,501 shares (20.0% of shares outstanding), held indirectly through By The Column Group III, LP and 2 others (Form 4, 2026-10-22).
- , a 10% owner: 3,813,501 shares (20.0% of shares outstanding), held indirectly through By The Column Group III, LP and 2 others, on a joint filing (Form 4, 2026-10-22).
- Column Group III, LP, a 10% owner: 3,813,501 shares (20.0% of shares outstanding), held indirectly through By The Column Group III, LP and 2 others, on a joint filing (Form 4, 2026-10-22).
Shares outstanding: 19,061,662 as of 2026-11-05, from the company's latest SEC cover page.
How much has Surrozen, Inc./DE raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-04-08 | $76.40M | $175M |
| Form D, 2024-04-19 | $193.02M | $193.02M |
Keep reading
More on Surrozen, Inc./DE and the records around it.
Surrozen, Inc./DE elsewhere on the record
- 5%+ stake filings Nov 2026
- Form D filing Apr 2025
Companies that share a holder
- 5AM Partners VII, LLC also filed stake reports on 1 other company: SKYE BIOSCIENCE, INC. (Sep 2026)
- Boxer Capital Management, LLC also filed stake reports on 1 other company: Q32 Bio Inc. (Nov 2026)
- BRAIDWELL LP also filed stake reports on 1 other company: Amanat Acquisition Corp. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/surrozen